Skip to main content

Table 1 Patient characteristics

From: Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Number of patients

n = 41

Age

Median

Range

 

69

60–92

Race

n

%

 Caucasian

26

63%

 African-American

15

37%

Prostate volume (cc)

Median

Range

 

37

20–63

PSA (ng/mL)

Median

Range

 

6.9

3.5–18.3

T Stage

n

%

 1b

1

2%

 1c

28

68%

 2a

6

15%

 2b

4

10%

 2c

2

5%

Gleason score

n

%

 3+3

9

22%

 3+4

23

56%

 4+3

9

22%

Number of risk factors*

n

%

 1

34

83%

 2

7

17%

 3

0

0%

  1. * Factors include PSA 10–20 ng/mL, Gleason 7, or T2b-2c.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us